MedPath

INVICRO

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

12

Active:0
Completed:12

Trial Phases

2 Phases

Early Phase 1:4
Phase 1:8

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (66.7%)
Early Phase 1
4 (33.3%)

Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain

Early Phase 1
Completed
Conditions
Alpha-Synucleinopathy
Parkinson's Disease
Dementia With Lewy Bodies
Multisystem Atrophy
Interventions
First Posted Date
2024-06-06
Last Posted Date
2025-02-19
Lead Sponsor
Invicro
Target Recruit Count
12
Registration Number
NCT06445465
Locations
🇺🇸

Invicro, New Haven, Connecticut, United States

Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein

Phase 1
Completed
Conditions
Parkinson Disease
Multisystem Atrophy
Healthy Volunteer
Interventions
First Posted Date
2022-03-10
Last Posted Date
2025-02-20
Lead Sponsor
Invicro
Target Recruit Count
5
Registration Number
NCT05274568
Locations
🇺🇸

Invicro, New Haven, Connecticut, United States

Plasma P-tau2017 and Quantitative Amyloid PET Imaging

Phase 1
Completed
Conditions
Alzheimer Disease
Interventions
First Posted Date
2021-12-20
Last Posted Date
2025-02-28
Lead Sponsor
Invicro
Target Recruit Count
140
Registration Number
NCT05164536
Locations
🇺🇸

Invicro, New Haven, Connecticut, United States

Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

Phase 1
Completed
Conditions
Healthy Volunteer
Interventions
First Posted Date
2021-08-17
Last Posted Date
2022-07-05
Lead Sponsor
Invicro
Target Recruit Count
3
Registration Number
NCT05009199
Locations
🇺🇸

Invicro, New Haven, Connecticut, United States

Evaluation of [18F]APN-1607 as a PET Biomarker

Phase 1
Completed
Conditions
Progressive Supranuclear Palsy
Healthy Volunteers
Interventions
Drug: [18F] APN-1607
First Posted Date
2021-08-16
Last Posted Date
2025-02-20
Lead Sponsor
Invicro
Target Recruit Count
12
Registration Number
NCT05005819
Locations
🇺🇸

Invicro, New Haven, Connecticut, United States

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath